Nebulized epinephrine is prepared using the standard 1:1,000 concentration (1 mg/mL), delivered undiluted or mixed with normal saline to reach a minimum volume of 4 mL in the nebulizer cup. It is primarily used in clinical settings for moderate to severe croup in children and for post-extubation airway swelling, and preparation follows weight-based dosing protocols rather than a one-size-fits-all recipe.
Why Epinephrine Is Nebulized
When inhaled as a fine mist, epinephrine acts directly on the swollen tissue lining the airway. Its effects on alpha-adrenergic receptors constrict blood vessels in the airway walls, which rapidly reduces swelling and opens the breathing passage. It also activates beta-adrenergic receptors, relaxing the smooth muscle around the airways. This combination makes it especially useful for conditions where mucosal edema is the main problem, such as croup, the barking-cough illness common in young children.
Nebulized epinephrine has become standard management for moderate and severe croup across North America. Children with severe croup are at risk of needing a breathing tube, and nebulized epinephrine can prevent that. It is also used in neonatal and pediatric intensive care for reactive airway swelling after a breathing tube is removed.
Which Form of Epinephrine to Use
Two forms exist: racemic epinephrine (a 50/50 mix of two mirror-image molecules) and L-epinephrine (the standard, single-isomer form found in regular epinephrine ampules). A randomized double-blind trial comparing the two in children with croup found no difference in effectiveness. Both produced significant, temporary reductions in croup severity scores and respiratory rates, with no difference in heart rate or blood pressure effects over time.
L-epinephrine is more widely available worldwide, less expensive, and carries no additional risk of side effects compared to the racemic version. For these reasons, standard L-epinephrine (1 mg/mL) is the practical choice in most settings.
Concentration and Dosing
The correct concentration for nebulization is epinephrine 1 mg/mL, also labeled as 1:1,000. This is the same concentration found in standard epinephrine ampules. It can be administered undiluted through a nebulizer.
The conventional weight-based dose for croup is 0.5 mg/kg, with a maximum of 5 mg per treatment. A low-dose protocol of 0.1 mg/kg (maximum 1 mg) has been studied, though the conventional dose remains standard practice. For neonatal post-extubation swelling, the dose is typically 0.5 mL/kg of the 1 mg/mL solution.
Preparation Step by Step
Start with the prescribed dose based on the patient’s weight. Draw up the appropriate volume of epinephrine 1 mg/mL into the nebulizer medicine cup. If the total volume of epinephrine is less than 4 mL, add enough 0.9% sodium chloride (normal saline) to bring the total volume to 4 to 4.5 mL. This minimum volume ensures the nebulizer produces a consistent mist for long enough to deliver the full dose.
As a practical reference from Médecins Sans Frontières guidelines:
- 2 mL epinephrine: add 2 mL normal saline
- 2.5 mL epinephrine: add 2 mL normal saline
- 3 mL epinephrine: add 1 mL normal saline
- 3.5 mL epinephrine: add 1 mL normal saline
- 4 mL or more epinephrine: no saline needed
Connect the nebulizer cup to the oxygen or air-driven source and set the flow rate to 6 to 8 liters per minute. At this flow, the nebulizer generates particles small enough to reach the upper and lower airways effectively. Use a face mask held close to the child’s face, as a mouthpiece is impractical for most young children. Allow the treatment to run until the cup sputters and no more mist is produced.
How Long the Effect Lasts
Nebulized epinephrine works fast but wears off fast. Most patients show noticeable improvement within 30 minutes, with maximum airway opening at about 60 minutes. By 120 minutes, roughly 30 to 40% of patients return to their pre-treatment baseline. This has historically been called a “rebound effect,” but research suggests it is simply the drug wearing off rather than a true worsening beyond the starting point. Studies comparing epinephrine and placebo groups found similar patterns of symptom return, confirming this is pharmacological offset, not rebound.
Because the relief is temporary, nebulized epinephrine is almost always given alongside a corticosteroid (typically a single oral dose of dexamethasone), which takes several hours to reach full effect but provides sustained symptom control well beyond the 90-to-120-minute window of epinephrine.
Monitoring After Treatment
The transient nature of the drug’s effect makes post-treatment observation essential. The American Academy of Pediatrics and the Canadian Paediatric Society both recommend at least 2 hours of observation after nebulized epinephrine. A patient can be considered for discharge if there is no stridor at rest and their symptoms have clearly improved after this period.
More recent practice leans toward severity-based observation. Moderate cases benefit from at least 3 hours of monitoring, while severe or high-risk patients may need 4 hours or longer. A study of 482 cases found that extending observation beyond 2 hours did not significantly change 48-hour return rates (5.2% for standard observation versus 4.8% for extended), but the extra time provides a safety margin for patients whose symptoms may recur.
Side Effects and Risks
Because epinephrine stimulates the cardiovascular system even when inhaled, the most common side effects are a fast heart rate, elevated blood pressure, tremors, and restlessness. Children may appear anxious or jittery during or shortly after the treatment. These effects are generally mild and resolve as the drug wears off.
More serious cardiovascular effects, including irregular heart rhythms, chest pain, or dangerous blood pressure spikes, are rare with nebulized delivery but are associated with overdose or using an incorrect concentration. Using epinephrine at a concentration higher than 1 mg/mL, or miscalculating a weight-based dose, increases the risk of peripheral tissue damage, dangerous blood pressure elevation, and abnormal heart rhythms. There are no absolute contraindications to epinephrine, but patients with certain heart rhythm conditions or sensitivity to stimulant-type drugs warrant extra caution.
Key Preparation Pitfalls
The most dangerous error is a concentration mix-up. Epinephrine comes in multiple concentrations for different routes of administration. The 1:10,000 concentration (0.1 mg/mL) is intended for intravenous use, while the 1:1,000 concentration (1 mg/mL) is the correct one for nebulization. Using the wrong concentration in either direction results in a dramatically wrong dose. Always verify the label reads 1 mg/mL before drawing up the solution.
Insufficient volume in the nebulizer cup is another common issue. If the total liquid volume falls below about 4 mL, the nebulizer may sputter out before the full dose is delivered, or it may produce an inconsistent mist. Topping up with normal saline solves this without altering the drug’s effectiveness. Finally, flow rates below 6 liters per minute produce larger droplets that deposit in the mouth and throat rather than reaching the target tissue in the trachea and lower airway.